Monday, November 18, 2019

CF Foundation | Plenary | Emerging Technologies "The Path to a Cure"


The Path to a Cure for Cystic Fibrosis

 Plenary I


Plenary II

Looking back to 1988 when my second son was born and diagnosed with cystic fibrosis from a vantage point over thirty years ago the path has been clear.  He was born fortuitously around the time when the CFTR gene was localized after the human genome was analyzed.  The future looks bright, and hopeful.    The Cystic Fibrosis Foundation is committing 500 million dollars over the next five years (2025) for future developments in treatment for CF.

Please watch and join Francis T. Collins, M.D., Ph.D., the Director of the National Institutes of Health and one of the discoverers of the double helix of DNA.

Please go to the time slot at 1:24:00/1:34 for his musical rendering of two songs dedicated to patients with cystic fibrosis

No comments: